Surgical Mesh Lawsuit News: Bernstein Liebhard LLP Notes Current Creation of New Federal Vaginal Mesh Litigation in Southern District of West Virginia


New York, NY (PRWEB) June 26, 2013

Surgical mesh lawsuit claims are continuing to move forward in a number of federal litigations at present underway in the Southern District of West Virginia, Bernstein Liebhard LLP reports.

&#13

According to court documents, a federal multi-district litigation for claims involving transvaginal mesh manufactured by Cook Healthcare, Inc. was authorized on June 11th by the U.S. Judicial Panel on Multidistrict Litigation. The initial status conference for this proceeding has been scheduled for August 1st at 9:00 a.m.* (In Re: Cook Medical, Inc., Pelvic Repair Technique Goods Liability Litigation – MDL No. 2440)

&#13

Lawsuits alleging injuries brought on by the companys mesh are now pending in the federal proceeding underway in the U.S. District Court, Southern District of West Virginia, where claims involving merchandise from American Medical Systems, C.R. Bard, Boston Scientific and Johnson &amp Johnsons Ethicon unit have currently been filed in separate litigations. On the date the Cook Health-related litigation was approved, court records indicate there had been 13 instances filed against the manufacturer in eight federal jurisdictions in the U.S.

&#13

Given how numerous women we hear from who have sustained mesh erosion, vaginal scarring and other injuries allegedly due to transvaginal mesh merchandise, we are not surprised that far more of these varieties of products are becoming the object of litigation, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is actively filing transvaginal mesh lawsuits on behalf of women who allegedly suffered pain, vaginal scarring, mesh erosion, infection and other injuries.

&#13

Surgical Mesh Lawsuits

&#13

In addition to lawsuits now pending in the recently developed federal litigation involving Cook Health-related mesh devices, thousands of claims have been filed in the four other transvaginal mesh proceedings established in the U.S. District Court, Southern District of West Virginia. These lawsuits have been filed by women who allegedly seasoned complications stemming from mesh erosion by means of the vaginal tissue, which could manifest in infection, discomfort, vaginal scarring, and other injuries. As a result, plaintiffs in these circumstances allege they now endure a diminished quality of life.

&#13

Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committees in the following four federal vaginal mesh litigations: In re: American Health-related Systems, Inc., Pelvic Repair Systems Merchandise Liability Litigation (MDL No. 2325) In re: Boston Scientific Corp., Pelvic Repair Systems Items Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation ( MDL No. 2327).

&#13

The scrutiny surrounding this class of devices has continued to mount given that 2008, when the U.S. Meals and Drug Administration (FDA) issued its initial public overall health alert warning the public that it had received far more than 1,000 adverse event reports from women implanted with the surgical material.** In 2011, the agency revised its stance on the frequency of these complications to occur from rare to not uncommon following finding that the number of complaints from vaginal mesh individuals improved 5-fold over a period of 3 years.***

&#13

Girls who could have been injured by transvaginal mesh may be eligible to get compensation for out-of-pocket medical costs, as well as lost wages, pain and suffering and other damages. Find out far more about surgical mesh lawsuits by going to Bernstein Liebhard LLP’s site. To speak with a mesh lawyer straight, call 800-511-5092.

&#13

*wvsd.uscourts.gov/MDL/2440/pdfs/PTO_1.pdf&#13

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm&#13

***fda.gov/MedicalDevices/Security/AlertsandNotices/PublicHealthNotifications/ucm061976.htm

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide because 1993, including these who have been harmed by harmful drugs, defective healthcare devices and consumer items. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the prime plaintiffs firms in the country, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Da Vinci Lawsuit News: Bernstein Liebhard LLP Notes Recent FDA Letter Stating Intuitive Surgical Could Have Violated Federal Regulations Regarding its da Vinci Robot


New York, NY (PRWEB) June 27, 2013

In a current notice from the U.S. Meals and Drug Administration (FDA) that might impact da Vinci lawsuit claims, the agency states that Intuitive Surgical possibly violated federal law by failing to initial alert regulators when it warned consumers about difficulties with the da Vinci Surgical Program, Bernstein Liebhard LLP reports.

&#13

According to the letter issued May 30th by the FDA, Intuitive Surgical received 134 complaints and filed 83 medical device reports stemming from use of the device between January 2010 and December 2011.* Following these reports, Intuitive sent a letter to buyers in October 2011 providing ideas and recommendations for appropriate use of the da Vinci Surgical Technique. According to a CNBC.com report published on June 25th, the FDA said Intuitive Surgical wrote to its customers in response to complaints concerning arcing by way of broken tip covers that caused patient injury.**

&#13

Intuitive Surgicals failure to very first notify the FDA begs the question of whether or not they were attempting to hide one thing from the regulator. We will be watching this improvement carefully. Our Firm continues to hear from individuals who allegedly skilled surgical burns, excessive bleeding and other critical undesirable robot surgery complications stemming from use of the da Vinci Surgical Technique, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm is presently supplying totally free and confidential case evaluations to individuals who may have experienced robotic surgery complications after undergoing a procedure aided by the da Vinci Surgical System. Da Vinci Lawsuit Claims

&#13

According to a statement issued April 19th by Intuitive Surgical, 26 da Vinci lawsuits alleging complications due to the surgery robot had been filed in the U.S. Court records indicate that the nations very first trial for a claim alleging robotic surgery complications concluded with a ruling in favor of Intuitive last month, but a May possibly 23rd report from Bloomberg.com stated that the lawyer for the plaintiff in the case was optimistic that future lawsuits more than the da Vinci Surgery Robot would result in favorable outcomes for allegedly injured sufferers.***(Estate of Fred E. Taylor v. Intuitive Surgical, 09-two-03136-5, Superior Court, State of Washington, Kitsap County)

&#13

In a regulatory filing with the U.S. Securities and Exchange Commission issued by Intuitive on April 19th, the manufacturer reported that it had entered tolling agreements in specific bad robot surgery lawsuits more than its da Vinci Surgical System to allow additional time to evaluate the claims, to discover regardless of whether the claims have merit and whether they can be resolved without having litigation.**** As of March 14th, 2013, a notice entered in the U.S. District Court, Eastern District of Louisiana on March 14th indicated that Intuitive had settled a lawsuit alleging injuries sustained by a woman whose thyroid process was aided by the da Vinci robot. (Silvestrini v. Intuitive Surgical Systems Inc., No. 11-2704 (E.D. La.))

&#13

The da Vinci Surgical Method was authorized in 2000 to aid surgeons performing minimally-invasive laparoscopic, urologic and gynecologic procedures. The device is now also utilized in thousands of hysterectomies, gall bladder and prostate removal surgeries, thyroid cancer procedures and heart surgeries, according to a Bloomberg.com report from February 28th.*****

&#13

Individuals who knowledgeable robotic surgery complications may possibly be entitled to compensation for healthcare bills, lost wages, discomfort and suffering and other damages incurred by their injuries. Understand a lot more about bad robot surgery complications by visiting Bernstein Liebhard LLPs website. To speak with one of the Firms attorneys, please call 800-511-5092.

&#13

*fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM358468.pdf&#13

**cnbc.com/id/100843549&#13

***bloomberg.com/news/2013-05-23/intuitive-wins-trial-defeats-negligent-coaching-claims.html&#13

****sec.gov/Archives/edgar/data/1035267/000119312513162385/d508282d10q.htm &#13

*****bloomberg.com/news/2013-05-23/intuitive-wins-trial-defeats-negligent-education-claims.html

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes those who have been harmed by dangerous drugs, defective health-related devices and consumer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Advertising.

Byetta Lawsuit Website Launched by Bernstein Liebhard LLP Gives Updated Byetta Pancreatic Cancer Details, Developing Investigation and Litigation


New York, NY (PRWEB) June 28, 2013

Bernstein Liebhard LLP has launched a new Byetta lawsuit website devoted to supplying data to patients who could have created pancreatitis, pancreatic cancer or thyroid cancer as a result of the diabetes drug.

&#13

The Firm is actively investigating the hazardous pancreatic dangers related with Byetta, a sort II diabetes drug involved in a class of drugs known as incretin mimetics. In addition to its new internet site, which contains information associated to side effects, as effectively as updates on the increasing nationwide litigation involving Byetta and other incretin mimetics which includes Januvia, Bernstein Liebhard LLP is providing totally free and confidential case evaluations to any person who may possibly have been diagnosed with any of the following diseases soon after taking the diabetes medication:&#13

&#13

Bernstein Liebhard LLP Launches Surgical Mesh Recall Site to Provide Details on Vaginal Mesh Complications, Mounting Litigation


New York, NY (PRWEB) June 29, 2013

Bernstein Liebhard LLP has launched a new surgical mesh recall web site providing information to girls looking for to file lawsuits alleging injuries triggered by transvaginal mesh.

&#13

The Firms new internet site, which was created to provide useful info to females who could be suffering from pain, infection, mesh erosion and other vaginal mesh complications, consists of particulars on side effects, the oftentimes tough approach of removing transvaginal mesh devices, and updates on the expanding nationwide litigation of lawsuits filed in the U.S.

&#13

In addition to its online platform, the attorneys at Bernstein Liebhard LLP are at the moment supplying cost-free and confidential case evaluations to ladies who could be experiencing 1 or far more of the following transvaginal mesh side effects:&#13

&#13

Biomet Hip Lawsuits Move Forward, As Bernstein Liebhard LLP Reports on Latest Case Management Conference in Federal Biomet Hip Replacement Litigation


New York, New York (PRWEB) July 01, 2013

Hundreds of Biomet hip lawsuits involving the Biomet M2a Magnum Hip Replacement Program continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana. According to a Memorandum issued by the Court on June 24th, the Biomet hip replacement litigations most recent case management conference was held on June 17, 2013, at which time a quantity of issues had been addressed, including pending motions to strike affirmative defenses, jurisdictional issues connected to the current dismissal of improperly named defendants, and the use of a kind complaint. At the conclusion of the conference, the parties presented a tutorial on the scientific and technical issues involved in the Biomet hip replacement lawsuits. (In re: Biomet M2a Magnum Hip Implant Items Liability Litigation MDL No. 2391)

&#13

This most current conference addressed a number of crucial concerns. We are pleased to see the Biomet hip replacement litigation moving ahead, and look forward to extra progress in the future, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is representing customers in Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply free of charge and confidential case evaluations to people who may possibly have been injured by Biomet M2a Magnum implants.

&#13

Biomet Hip Replacement Lawsuits&#13

Court documents indicate that far more than 300 Biomet hip lawsuits are now pending in the federal multidistrict litigation. All of the claims allege the Biomet M2a Magnum implants metal-on-metal design can shed dangerous amounts of toxic metal debris as a outcome of wear, top to metallosis and other adverse tissue reactions, as effectively as premature device failure. According to the June 17th Memorandum, the Biomet hip replacement litigations next case management conference has been scheduled for September 23, 2013, whilst a telephonic status conference is set for July 29, 2013.

&#13

The U.S. Meals &amp Drug Administration (FDA) has been reviewing the security of metal-on-metal hip implants like the Biomet M2a Magnum considering that February 2011. In January, the FDA warned that the metal debris shed from these devices can trigger damage to bone and/or tissue surrounding the implant and joint, top to discomfort, implant loosening, device failure, and the want for revision surgery to replace the device. At that time, the agency advised recipients of metal-on-metal hip replacements to undergo metal ion testing if they are experiencing symptoms of hip implant failure. The FDA also stated it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed such devices to come to market place with out first undergoing human clinical trials.*

&#13

Alleged victims of metal-on-metal hip implant complications associated to the Biomet M2a Magnum hip could be entitled to compensation for their medical expenditures, lost wages and discomfort and suffering. To understand far more about the Biomet hip replacement litigation, please check out Bernstein Liebhard LLPs website. For further data about filing a Biomet hip lawsuit, please contact 1 our attorneys today at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective health-related devices and customer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Advertising.

Transvaginal Mesh Lawsuit News: Federal Judge Overseeing American Healthcare Systems Surgical Mesh Lawsuits Selects Bellwether Instances, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) July 02, 2013

Transvaginal mesh lawsuit claims involving items manufactured by American Medical Systems, Inc. continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on July 1, 2013, four surgical mesh lawsuits have been chosen for the litigations bellwether trials. The proceedings initial trial is scheduled to start on December 3, 2013, even though a second is slated to start off on Might six, 2014. U.S. District Judge Joseph R. Goodwin will soon establish which of the 4 bellwether instances will go to trial on those dates, according to the Order. (In Re: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation – MDL No. 2325)

&#13

We are incredibly pleased to see these claims moving forward. The bellwether trials will give important clues into how other juries may possibly weigh claims in similar surgical mesh lawsuits involving American Medical Systems, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firms vaginal mesh lawyers are currently representing hundreds of girls who allegedly suffered mesh erosion, discomfort, scarring, infection and other serious injuries, allegedly due to transvaginal mesh merchandise marketed by American Health-related Systems and other manufacturers. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committee in the American Healthcare Systems litigation.

&#13

American Health-related Systems Transvaginal Mesh Lawsuits

&#13

Court documents indicate that a lot more than 7,700 surgical mesh lawsuits have been filed against American Healthcare Systems in the Southern District of West Virginia. All of the lawsuits pending in the litigation allege that American Healthcare Systems failed to provide adequate warnings with regards to the dangers linked with surgical mesh utilized to treat pelvic organ prolapse and stress urinary incontinence. It is additional alleged that plaintiffs suffered a range of serious complications due to the defective nature of these items, including chronic infections, organ harm, and mesh erosion and shrinkage.

&#13

The litigation surrounding transvaginal mesh devices utilized to treat pelvic organ prolapse and stress urinary incontinence has been expanding given that October 2008, when the U.S. Food &amp Drug Administration (FDA) warned the public that it had received a lot more than 1,000 reports of serious complications linked with vaginal mesh products over a 3 year period.* Less than 3 years later, in July 2011, the FDA warned that complaints related with transvaginal prolapse repair had grown 5-fold because the 2008 alert, and stated that it no longer regarded as these varieties of injuries to be uncommon.**

&#13

American Healthcare Systems is just 1 of many producers involved in litigations for surgical mesh lawsuits established in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs Steering Committees for proceedings involving Boston Scientific Corp., (MDL No. 2326) C.R. Bard, Inc., (MDL No. 2187), and In re: Ethicon, Inc. (MDL No. 2327). Court documents show that the very first of the litigations bellwether trials, involving a C.R. Bard product, is scheduled to start on July 8, 2013.

&#13

Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are at present underway in New Jerseys Atlantic County Superior Court. He was also a member of the trial group on the very first Ethicon trial in that proceeding, which ended in March with an $ 11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten)

&#13

Ladies who have allegedly suffered severe complications related with transvaginal mesh may possibly be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of data with regards to transvaginal mesh lawsuits is obtainable at Bernstein Liebhard’s web site. To arrange for a free of charge legal consultation with an experienced mesh lawyer, please get in touch with the Firm these days by calling 800-511-5092.

&#13

*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm&#13

**fda.gov/MedicalDevices/Security/AlertsandNotices/PublicHealthNotifications/ucm061976.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated person and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective healthcare devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

DePuy Pinnacle Lawsuits Continue to Mount, as Federal Claims Exceed 4,400, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) July 03, 2013

DePuy Pinnacle lawsuit claims involving an all-metal version of the DePuy Pinnacle Hip Replacement Program continue to mount in the federal multidistrict litigation underway in U.S. District Court, Northern District of Texas, Bernstein Liebhard LLP reports. According to a Master Case List issued by the Court on July 1, 2013, 4,445 DePuy Pinnacle hip replacement lawsuits were pending in the proceeding as of June 30th. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244 N.D. Texas)

&#13

Our Firm continues to receive inquiries from individuals who have suffered metallosis, premature device failure and other serious complications allegedly related with the metal-on-metal DePuy Pinnacle hip replacement. We anticipate that filings in this litigation will continue to increase in the coming months, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. Jeffrey S. Grand, a companion with Bernstein Liebhard LLP, serves on the Plaintiffs Steering Committee for the federal litigation, while the Firms DePuy Pinnacle lawyers continue to offer you cost-free legal evaluations to alleged victims of severe complications connected with the all-metal DePuy Pinnacle Hip Replacement Method.

&#13

DePuy Pinnacle Hip Replacement Lawsuits&#13

All of the DePuy Pinnacle hip replacement lawsuits pending in the Northern District of Texas involve a version of the Pinnacle hip method that utilized the Ultamet liner. According to court documents, plaintiffs allege that they have suffered premature implant failure, metallosis and other serious complications due to the propensity of the device to shed dangerous amounts of metal ions into the tissue surrounding the implant, as effectively as the blood stream. The lawsuits further allege that the all-metal Pinnacle shares some of the same style flaws that prompted DePuy Orthopaedics to recall its ASR line of metal hip implants in 2010, and question no matter whether this version of Pinnacle program must have been recalled as properly.

&#13

Even though it does not seem that a DePuy Pinnacle recall is imminent, DePuy Orthopaedics did announce in May possibly that it would be ending sales of all-metal hips, which includes the metal-on-metal Pinnacle. While the firm did not cite the increasing number of DePuy Pinnacle hip replacement lawsuits as a contributing issue to this selection, it did note that demand for metal-on-metal hips has slipped in recent years. According to a May 17th report from The New York Occasions, DePuy also cited a proposed regulation from the U.S. Food &amp Drug Administration (FDA) that would demand the producers of metal-on-metal hips at the moment on the industry to conduct post-marketplace safety research in order to preserve promoting the goods.*

&#13

Victims of significant complications allegedly associated with the metal-on-metal DePuy Pinnacle hip implant may possibly be entitled to compensation for their healthcare care, discomfort and suffering, and other damages. Added details about filing a DePuy Pinnacle hip replacement lawsuit is offered at Bernstein Liebhards site. For a free, no obligation legal consultation with a DePuy Pinnacle lawyer, please call 800-511-5092 today.

&#13

*nytimes.com/2013/05/17/company/jj-is-phasing-out-metal-replacement-hips.html?ref=health&amp_r=

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by dangerous drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Advertising.

Mirena Lawsuits Move Ahead, as Case Management Conference is Convened in New Jersey Litigation, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) July 04, 2013

Mirena lawsuit claims filed on behalf of ladies who have allegedly suffered significant complications, such as spontaneous device migration and uterine perforations, due to their use of the IUD, are moving forward in each state and federal courts, Bernstein Liebhard LLP reports. Court documents indicate that a Case Management Conference was held on July 1st in the consolidated litigation established for Mirena IUD lawsuits in New Jerseys Bergen County Superior Court. According to an Order issued by the Court on July 2nd, attorneys for the parties have been directed to meet and confer within 30 days to reach agreement on a quantity of issues, including the status, scope, parameters and timing of discovery. The Court also scheduled the litigations next Case Management Conference for August 13, 2013. (In Re: Mirena Litigation Case No. 297)

&#13

Our Firm is actively representing women in Mirena lawsuits, and we continue to hear from alleged victims of critical Mirena complications, including spontaneous device migration and uterine perforations. We are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free of charge legal evaluations to alleged victims of Mirena side effects.

&#13

Mirena IUD Lawsuits&#13

The Mirena IUD was approved by the U.S. Food &amp Drug Administration (FDA) as a birth control strategy in 2000, and later as a remedy for heavy menstrual bleeding in females who wish to use an IUD as their main form of birth handle. According to court documents, Mirena lawsuits allege that Bayer Healthcare Pharmaceuticals downplayed its severe risks and failed to supply sufficient warnings concerning the prospective for spontaneous migration of the Mirena IUD. In addition to the consolidated litigation now underway in New Jersey Superior Court, a multidistrict litigation was not too long ago established in U.S. District Court, Southern District of New York for all federally-filed Mirena IUD lawsuits. A Status Conference in the federal multidistrict litigation was held on July 2nd. (In re: Mirena IUD Items Liability Litigation, MDL No. 2434)

&#13

According to a June 17th report from NewsChannel5 in Cleveland, the FDA has received more than 70,000 adverse occasion reports involving Mirena given that the device was launched in 2000. Information from the FDA also indicated that given that 2008, the agency had received a lot more than 4,700 complaints of device dislocation involving Mirena, and 1,300 reports of uterine perforations. Despite these mounting adverse event reports, there has been no indication that Bayer may be arranging to announce a Mirena IUD recall any time in the future.*

&#13

Whilst a Mirena recall does not appear imminent, the FDA has taken problem in the past with some of the claims Bayer has utilised in marketing campaigns for the IUD. In 2009, the agency issued a warning letter to Bayer after obtaining that its Mirena promotions overstated the efficacy of the device and minimized its dangers. Amongst other items, the letter cited Bayer for producing statements that indicated that Mirena would assist a lady look and really feel wonderful, and enhance her sex life.**

&#13

Ladies who have allegedly suffered significant Mirena complications following spontaneous migration of the IUD may be entitled to compensation for their health-related bills, lost wages, discomfort and suffering and other damages. To find out a lot more about Mirena lawsuits, please go to Bernstein Liebhard LLPs site. To arrange for a cost-free evaluation of your potential Mirena IUD lawsuit, please contact 800-511-5092.

&#13

*newsnet5.com/dpp/news/local_news/investigations/thousands-of-females-complain-about-harmful-complications-from-mirena-iud-birth-handle&#13

*http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as these who have been harmed by harmful drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Da Vinci Lawsuit News: Bernstein Liebhard LLP Comments on Enhanced Use of Robotic Surgery to Treat Low-Grade Prostate Cancer


New York, New York (PRWEB) July 04, 2013

As da Vinci lawsuit claims alleging injury due to the use of the da Vinci Surgical Technique continue to move forward in courts all through the country, Bernstein Liebhard LLP notes that a new study has located that robotic surgery is being increasingly used to treat men with low-grade prostate cancer, even even though these varieties of procedures could not offer you them any added rewards. According to the study, which was published in the Journal of the American Medical Association on June 26th, the use of robotic surgery and other advance treatments in males with low-grade prostate cancer rose from 32 percent to 44 percent amongst 2004 and 2009.*

&#13

Low-grade prostate cancer is defined as slow-increasing cancer that doesnt pose a threat to a patients life. According to a report from NPR.com, the new study has raised issues, as there is small data to indicate that robotic surgery gives added advantages to individuals with this type of prostate cancer, and might even have harmful effects. Robotic procedures are also far far more high-priced compared to standard types of surgery and radiation.**

&#13

As the NPR report points out, several sufferers are drawn to robotic procedures because of marketing and advertising claims promising shorter recoveries and other benefits. However, as the developing quantity of da Vinci surgery lawsuits makes clear, the true dangers of robotic surgery nevertheless want to be fully evaluated, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is presently providing free legal evaluations to individuals who allegedly suffered severe robotic surgery complications in procedures involving the da Vinci Surgical Technique, including da Vinci prostatectomy.

&#13

Da Vinci Surgery Lawsuits&#13

The da Vinci Surgical System was brought to industry in 2000 by Intuitive Surgical, Inc., and is the only robotic surgery platform approved in the U.S. for soft tissue procedures. According to a June 14th report from NBC News, the robot was utilised in more than 400,000 procedures final year, like thousands of men who underwent a da Vinci prostatectomy. The very same broadcast also revealed that the U.S. Food &amp Drug Administration (FDA) has received much more than 200 reports of da Vinci patients who suffered burns, cuts and infections since 2007, such as 89 that involved patient deaths. The developing number of da Vinci complications has attracted scrutiny from the FDA, and in January it launched a survey of medical doctors to determine if the increase was related to a problem with the technology. ***

&#13

On Might 30th, the FDA issued a 483 letter to Intuitive Surgical soon after an agency inspection of its headquarters revealed that the organization had not informed the FDA of a letter it sent to buyers in October 2011 concerning a problem with the da Vinci that had the potential to harm individuals. According to the FDA letter, Intuitive Surgical had received 134 complaints and filed 82 healthcare device reports associated to tip cover issues amongst January 2010 and December 2011 that allowed electricity to arc, or jump, inside individuals during surgery.**** Just weeks prior, on May 8th, Intuitive sent an Urgent Healthcare Device Notification to its clients after figuring out that micro-cracks in an instrument used with the da Vinci could result in surgical burns. The business has redesigned the instrument and is now shipping replacements.*****

&#13

Intuitive Surgical also acknowledged in an April 19th filing with the U.S. Securities and Exchange Commission that it had been named in 26 da Vinci surgery lawsuits filed on behalf of patients who allegedly suffered critical complications in robotic procedures.****** Although Intuitive lately won the nations 1st trial involving a da Vinci lawsuit, Reuters reported on May possibly 28th that plaintiffs attorneys expect hundreds of similar filings in the future. ******* (Estate of Fred E. Taylor v. Intuitive Surgical Inc., 09-two-03136-five, Superior Court, State of Washington, Kitsap County (Port Orchard))

&#13

Victims of severe injuries allegedly brought on by the da Vinci Surgical System could be entitled to compensation for healthcare expenditures, lost wages, discomfort and suffering, and far more. To find out much more about filing a da Vinci surgery lawsuit, please visit Bernstein Liebhard LLPs site. Free of charge, no-obligation legal evaluations can also be arranged by calling 800-511-5092.

&#13

*jama.jamanetwork.com/article.aspx?articleid=1700496&#13

**npr.org/blogs/wellness/2013/06/26/195835806/males-pick-robotic-surgery-for-prostate-cancer-despite-risks&#13

***rockcenter.nbcnews.com/_news/2013/06/14/18958967-robotic-surgery-is-high-tech-tour-de-force-but-is-it-secure&#13

****fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM358468.pdf&#13

*****.cnbc.com/id/100726886&#13

****** sec.gov/Archives/edgar/information/1035267/000119312513162385/d508282d10q.htm &#13

*******newsandinsight.thomsonreuters.com/Legal/News/2013/05_-_Could/Intuitive_Surgical_wins_case_over_robotic_surgery_method/

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide since 1993, including those who have been harmed by unsafe drugs, defective healthcare devices and consumer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Januvia Lawsuit Web site Launched by Bernstein Liebhard LLP to Give Information About Possible Januvia Side Effects, Such as Januvia Pancreatic Cancer


New York, New York (PRWEB) July 03, 2013

A new Januvia lawsuit internet site has been launched by Bernstein Liebhard LLP to supply details to men and women who might be concerned about potential Januvia side effects, such as Januvia pancreatic cancer, Januvia pancreatitis and Januvia thyroid cancer. The internet site will also be updated regularly with the most existing data concerning the increasing litigation surrounding the type 2 diabetes drug and its alleged association with pancreatic cancer, pancreatitis, and thyroid cancer.

&#13

Januvia and comparable variety 2 diabetes drugs are coming beneath elevated scrutiny amid concerns that they may possibly boost the danger that a patient will develop pancreatic cancer, pancreatitis or thyroid cancer. This site will offer valuable info to worried sufferers and their households concerning the prospective risks connected with Januvia, as effectively as their choices for legal recourse, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm is currently offering free of charge Januvia lawsuit consultations to any person who might have been harmed right after taking Januvia or a similar drug.

&#13

Januvia Lawsuits

&#13

Januvia belongs to a class of type2 diabetes drugs identified as incretin mimetics, which support regulate blood sugar by stimulating insulin production by the pancreas. The U.S. Food &amp Drug Administration (FDA) announced in March that it was investigating incretin mimetics following benefits from an unpublished study indicated these drugs may possibly cause pre-cancerous adjustments in the pancreas.* Most recently, a report published June 10th in the British Health-related Journal revealed previously unpublished information that indicated the producers of incretin mimetics could have downplayed the drugs possible to harm the pancreas.**

&#13

In 2009, a caution relating to a possible Januvia pancreatitis threat was added to the drugs label right after the FDA became conscious of 88 post-advertising cases of acute pancreatitis in individuals taking Januvia.*** In 2011, a study published in Gastroenterology discovered that use of Januvia appeared to increase the danger of pancreatitis and pancreatic cancer, while two circumstances of thyroid cancer have been also reported in the individuals who took Januvia.****

&#13

Court documents indicate that Merck &amp Co. has been named in a quantity of lawsuits filed on behalf of individuals who allegedly developed Januvia pancreatic cancer, Januvia pancreatitis, or Januvia thyroid cancer. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear Oral Arguments on July 25, 2013, relating to the proposed establishment of a multidistrict litigation for all federally-filed claims involving incretin mimetics, Which includes Januvia lawsuits. (In Re: Incretins Items Liability, Sales and Advertising and marketing Litigation, MDL 2452, JPML)

&#13

Individuals who have allegedly developed Januvia pancreatic cancer, thyroid cancer or pancreatitis could be entitled to compensation for medical bills, lost wages, pain and suffering and far more. To learn more about filing a Januvia lawsuit, please check out Bernstein Liebhard LLPs internet site. For a lot more info, please call 800-511-5092.

&#13

*fda.gov/Drugs/DrugSafety/ucm343187.htm&#13

**bmj.com/open-data/incretin#alternate BMJ, June 10, 2013&#13

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm September 25, 2009 &#13

***gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide considering that 1993, including these who have been harmed by hazardous drugs, defective health-related devices and consumer items. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the country, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.